Columbus, OH. One of the trends the innovation team is tracking is “More Involved Patients” – the increasing expectation of patients to be active participants in their healthcare. In fact, the vast majority, ‘81% of patients want an equal say in care decisions with their care provider’ – PWC. And, we know that when this agreed-upon treatment planning or shared decision making (SDM) occurs, the impact on adherence is significant. According to the SDM report 2015 by medical practice management software consultancy Software Advice: ‘41% of patients report that they would be “much more likely” to adhere to a treatment plan developed using SDM and improves patient satisfaction by 89%.’

It follows that there would be shifts in the tools that doctors are using to create treatment plans collaboratively with their patients.

So, I set out to find what kinds of tools and software were being developed and used in the clinical setting to facilitate this collaborative treatment planning.

One of the innovators in the shared decision making movement, the Mayo Clinic, has an innovative set of interactive tools specific to disease states.

In the Diabetes space, each aspect of the treatment, including cost, is detailed in a worksheet format so that the patient can clearly see and agree to the plan.


The Bone Health decision aid pulls in the patient’s own analysis of fall risk from based on the FRAX calculator.

Another tool, Option Grids, has developed a web tool that clearly maps out visual comparisons on different treatments.

About the Author:

As Managing Director of Innovation and Insights for Syneos Health Communications, Leigh is responsible for building and scaling a global team of healthcare experts who together help life science leaders better understand the complex lives, influences and expectations of their customers. Specifically, they uncover actionable insights that fuel empathy and creativity; lead co-creation events that let marketers learn from peers, trends, and new possibilities; and help clients identify the most valuable and useful new customer experiences to create.

Leigh has worked with Fortune 1000 companies to craft their digital, mobile, social and CRM strategies for nearly 20 years.She’s worked for category-leading agencies in retail, public affairs, B2B technology, and higher education. Prior to moving to Syneos Health Communications, she held several leadership roles at our largest agency, GSW.  There, she founded an innovation practice fueled by the zeitgeist and spearheaded digital and innovation thinking across the business.

Leigh has taken a special interest in complex healthcare products that can change lives in meaningful ways. She was recently a strategic lead on the 3rd largest launch in pharmaceutical history: Tecfidera. Before that she had keys roles with Eli Lilly Oncology, Abbott Nutrition, Amgen Cardiovascular, and Eli Lilly Diabetes.

A critical part of Leigh’s work is trends and new ideas. Every year, she convenes a group of trend watchers from across our global network to identify the shifts most critical to healthcare marketers. This year, she led over 250 experts to experts to focus on the most important changes in the commercial, consumer, marketing, digital and healthcare landscapes. (See reports at

Leigh is a sought-after writer and speaker. Recognized as one of the most inspiring people in the pharmaceutical industry by PharmaVoice and Top 10 Innovation Catalysts of 2017 by MM&M, Leigh also was recognized  as a Rising Star by the Healthcare Businesswomen's Association (HBA) for her overt passion, industry thought leadership and significant contributions in new business, strategy and mentoring.